News & Blog

News & Blog

  • Blog

    09 August 2018

    The CA125 blood test: your questions answered

    A CA125 blood test should be requested if a doctor suspects a patient's symptoms could be caused by ovarian cancer.
    Blood test
  • Blog

    07 August 2018

    Back to the lab, cycling training and old vans

    Professor Bob Brown's research focuses on epigenetics and drug resistance – why chemotherapy sometimes stops working for patients with ovarian cancer. Later this year his partner, Justine, will cycle 240 miles from London to Paris over 3 days for Women V Cancer, raising money for three women's cancer charities, including Ovarian Cancer Action. Bob provides an update on the highs and lows of training and his vital ovarian cancer research that Women V Cancer helps to fund.
    Flora van
  • Blog

    27 July 2018

    Talcum powder: what's the story?

    After the latest round of pay-outs Johnson & Johnson have been ordered to pay $4.7bn (£3.6bn) to women who claim their ovarian cancer was caused by using talcum powder. Ovarian Cancer Action investigates the facts behind this on-going legal case.
    Johnsons baby powder
  • News

    26 July 2018

    Could regular aspirin use reduce ovarian cancer risk?

    There have been a series of reports recently claiming that taking aspirin can play a major role in both preventing ovarian cancer and increasing survival rates in women who already have the disease.
  • News

    25 July 2018

    10,000 signatures and counting — we did it!

    Over the past few months, thousands of you have signed and shared the petition to the UK Government to fund a national clinical audit for ovarian cancer. Thanks to you, the petition has now reached 10,000 signatures, meaning we can expect a government response in due course.
    10,000 signatures
  • Blog

    19 July 2018

    Cannabis oil and ovarian cancer: the facts

    Using cannabis oil as a means to treat or cure cancer is a topic of much online debate and the internet is full of people claiming that it has effectively helped to cure their cancer. We take a closer look at the evidence behind these claims.
    Cannabis oil
  • Blog

    18 July 2018

    Bloating: your questions answered

    People will describe bloating in slightly different ways, but usually, it is the uncomfortable feeling of tightness or distention around the abdomen. It might be accompanied by pain or the increased need to pass wind.
  • Your Stories

    16 July 2018

    Alan Roberts

    Alan Roberts pays tribute to his beloved wife, Carys, who lost her life to ovarian cancer in March this year. A hugely talented artist, the sale of Carys's artwork has left an incredible legacy, helping to raise £25,000 for a number of cancer charities.
    Carys Roberts
  • Blog

    13 July 2018

    In the news: ovarian cancer and talcum powder

    Johnson & Johnson has been ordered to pay £3.6bn in damages to women who claim the company’s baby powder and other talcum powder products caused them to develop ovarian cancer. Our Chief Executive explains why today’s news is no cause for alarm.
    Talcum powder
  • Blog

    10 July 2018

    The sky's the limit: Anika takes the leap for Ovarian Cancer Action

    This month, Anika Roob faced her fears and took part in a skydive for Ovarian Cancer Action. Ovarian cancer has had a devastating effect on Anika's family and she wanted to challenge herself and raise money to help fund research to protect future generations of women.
    Anika skydive
  • News

    10 July 2018

    Allyson Kaye to step down as Chair after 13 years

    After 13 years as Chair of Ovarian Cancer Action, Allyson Kaye MBE has announced her decision to step down. We are delighted that Allyson will continue her close connection with the charity in her new role of President, acting as an advisor and ambassador. Our current Vice-Chair, Dr Wayne Phillips has been appointed in her stead and Allyson will work closely with Wayne and the board as they embark on an exciting new chapter for the charity.
    Allyson Next 10
  • Blog

    04 July 2018

    Celebrating 70 years of the NHS

    The National Health Service turns 70 on 5 July 2018. We wanted to take this opportunity to appreciate the vital role the service plays in the lives of women with ovarian cancer, and to recognise and thank the extraordinary NHS staff – the everyday heroes – who are there to guide, support and care for them, day in, day out.
  • Blog

    04 July 2018

    "My story proves how important it is to have an understanding of your family history"

    Jess, 24, discovered she was BRCA2+ after her father was contacted by a relative who had tested positive. She describes the ups-and-downs of the past year, and why she now feels empowered by knowing her genetic status.
    Jess Martin2
  • News

    28 June 2018

    More women could be eligible for groundbreaking ovarian cancer drug

    The Telegraph has reported today that the latest trials of the drug Olaparib (Lynparza) have produced results that could make it accessible for a significantly increased number of women with advanced stage ovarian cancer.
    Young scientist
  • Your Stories

    27 June 2018

    Natasha Cantor

    Natasha has Lynch Syndrome, a genetic mutation which is linked to an increased risk of a number of different cancers. She tells us about her own family history, and why knowing her genetic status has allowed her to feel more in control.
    Natasha Cantor
  • News

    20 June 2018

    Ovarian Cancer Action receives £150,000 at NEX Giving Day

    Ovarian Cancer Action was honoured to have been nominated as one of the six chosen charities for the first NEX Giving Day, held in London on 7th June.
    NEX Giving Day
  • Blog

    18 June 2018

    "Before I was told I was BRCA positive, I had very limited knowledge of what it was"

    Andrea is 40, and mum to three girls. She recently discovered both she and her youngest daughter are BRCA2 positive.
    Andrea Baker
  • News

    15 June 2018

    Ovarian Cancer Action scientists discover mechanism that ‘deactivates’ ovarian cancer cells

    Scientists at the Ovarian Cancer Action Research Centre at Imperial College London have discovered a mechanism that deactivates ovarian cancer cells, which could lead to better treatments for women with ovarian cancer.
    Cancer cells
  • Your Stories

    12 June 2018

    Rachel Firmin

    Rachel pushed for genetic testing after losing her mum to breast cancer and discovered that she was BRCA2+. She shares her story.
    Rachel Firmin
  • News

    10 June 2018

    Ovarian Cancer Action launches Hereditary Cancer Risk Tool

    This week sees the launch of Ovarian Cancer Action's Hereditary Cancer Risk Tool, which has been developed to help people identify their cancer risk. We believe everyone has the right to understand if their family history puts them at risk of ovarian and other cancers, as well as the risk-reducing options available.
    Risk tool